Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Oral Medication for CTD-ILD Treatment

NCT01424033 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01424033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01424033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Oral Medication for CTD-ILD Treatment
Lead sponsor
University of Michigan
Phase
Phase 2/3
Overall status
Terminated
Start date
December 31, 2011
Completion date
Not reported
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

connective tissue disease, interstitial lung disease